Cespira Signs Agreement to Supply Components for a Customer Truck Trial

Executive Summary

• Cespira, the Westport‑Volvo joint venture, has signed an agreement and received full payment from a leading OEM for several hundred sets of HPDI™ components to be used in a customer truck trial.
• The trial will evaluate market interest and viability of the direct‑injection system in heavy‑duty trucking and could lead to further investment and commercialization if successful.
• Some ancillary system components used in the trial have not been validated by Cespira; details of the trial remain confidential for commercial reasons.

Key Details

• Agreement & Payment: Full payment received from a leading OEM for delivery of several hundred HPDI™ component sets.
• Component Delivery: Cespira will supply “several hundred” sets of the key HPDI™ component to support the truck trial.
• Trial Objective: Assess market interest and technical viability of the direct‑injection system in specific heavy‑duty trucking markets; results will inform OEM’s decision on further investment/commercialization.
• Validation Note: Certain other system components used in the trial are not validated by Cespira, highlighting a risk factor for performance assessment.
• Commercial Sensitivity: Specifics of the trial (e.g., OEM identity, exact quantities, timelines) are withheld due to commercial sensitivity.

Notable Quotes

(No direct quotes were provided in the release.)